About DAASO Pharma
DAASO Pharma is a Healthcare company. Pharmaceutical manufacturing, exporting, and supplying of medicines in India. Its Indian entity Daaso Pharmaceuticals Private Limited reported revenue of ₹1.31 Cr. DAASO Pharma offers products and services including Synapse Plus and Q Carni 10. Its focus areas include Trade and Services, Medicine Exporting, International Supply and Pharmaceuticals.
Company details
DAASO Pharma is recognized as an upcoming and fast-growing pharmaceutical company that emphasizes the delivery of scientifically designed combinations with a promise of highest quality. A focus is placed on ensuring these products are cost-effective and accessible to a larger segment of society, aligning with the vision of a healthy and strong India. Quality is prioritized through well-tested formulations in dietary supplements and medicines, while efforts are made to meet market demands without compromise.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Daaso Pharmaceuticals Pvt. Ltd
- Date of Incorporation 27 Feb, 2018
- Jurisdiction Nagpur, Maharashtra, India
- Indian entity revenue₹1.31 Cr
FY 2025 · +23% YoY
- Indian entity net loss-₹49.3 Lakh
FY 2025 · -38% margin
- Indian entity EBITDA-₹49.2 Lakh
FY 2025 · -38% margin
Associated legal entities of DAASO Pharma
DAASO Pharma operates through Daaso Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Daaso Pharmaceuticals Private Limited CIN U74999MH2018PTC305693 | Active | 27 Feb 2018 | Nagpur, Maharashtra | ₹1.3 Cr | 3 | View details |
Products & Services of DAASO Pharma
DAASO Pharma offers a comprehensive portfolio of products and services, including Synapse Plus and Q Carni 10.
A high-strength Omega-3 FA and Vitamin D-3 syrup is provided for health support
High-strength L Carnitine with Co enzyme Q10 syrup is supplied to boost mitochondrial functions
Board of directors of Daaso Pharmaceuticals Private Limited (DAASO Pharma)
Daaso Pharmaceuticals Private Limited is the primary company behind DAASO Pharma. The board of Daaso Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Sushil Tarachand Bagde, appointed in 2018. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sushil Tarachand Bagde DIN 08075543 | Director | 27 Feb 2018 | 8 yrs 8 mo | Daaso Pharmaceuticals Private Limited |
| Pallavi Amarjeet Wagh DIN 08617786 | Director | 23 Nov 2019 | 6 yrs 11 mo | Daaso Pharmaceuticals Private Limited |
| Deepak Hiralal Gajghate DIN 09627333 | Director | 06 Jun 2022 | 4 yrs 4 mo | Daaso Pharmaceuticals Private Limited |
Financials of DAASO Pharma
Figures of Daaso Pharmaceuticals Private Limited, the primary company behind DAASO Pharma, for FY 2025. Revenue was ₹1.31 Cr (+23% year on year). Net loss was -₹49.3 Lakh (-38% margin). EBITDA was -₹49.2 Lakh (-38% margin). Revenue has grown at a compounded annual rate of +20% over three years and +20% over five years.
- ₹1.31 CrRevenue · FY 2025 · +23% YoY
- -₹49.3 LakhNet loss · -38% margin
- -₹49.2 LakhEBITDA · -38% margin
- ₹1 LakhPaid-up capital
- +20%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Daaso Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for DAASO Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DAASO Pharma
The primary company behind DAASO Pharma, Daaso Pharmaceuticals Private Limited, reported revenue of ₹1.31 Cr for FY 2025, up 23% year on year.
DAASO Pharma is recognized as an upcoming and fast-growing pharmaceutical company that emphasizes the delivery of scientifically designed combinations with a promise of highest quality. A focus is placed on ensuring these products are cost-effective and accessible to a larger segment of society, aligning with the vision of a healthy and strong India. Quality is prioritized through well-tested formulations in dietary supplements and medicines, while efforts are made to meet market demands without compromise.
DAASO Pharma offers Synapse Plus and Q Carni 10.
DAASO Pharma operates through Daaso Pharmaceuticals Private Limited.
The legal entities of DAASO Pharma currently have 3 directors, including Pallavi Amarjeet Wagh, Sushil Tarachand Bagde, Deepak Hiralal Gajghate.